Vitals ranks America’s top cities for access to health care
LYNDHURST, N.J. — What’s the best U.S. city for health care? According to the Vitals Index second annual report on “America’s Top Cities for Access to Health Care,” Cleveland takes the top spot.
America’s Comeback City has the highest per-capita ratio of both hospitals and primary care physicians per resident. Cleveland toppled Boston, which held the top spot in 2013, but moved to No. 5 on the list this year. Minneapolis, Milwaukee, and Kansas City made up spots No. 2, No. 3 and No. 4, respectively.
As issues like doctor shortages and rising costs become more burdensome, easy access to quality health care becomes more important to the aging American population. Large metropolises, like Los Angeles, which was ranked No. 46, need more doctors and hospitals in order to keep pace with their population growth, Vitals stated.
“Cities — along with rural areas — need to address the large disparities that exist in accessing care across the nation” stated Mitch Rothschild, CEO of Vitals. “The rise of alternative care facilities, along with more nurse practitioners and the advancement of telemedicine technology all can help bring more affordable quality care options to consumers.”
To create the list of America’s Top Cities for Access to Health Care, Vitals analyzed the number of hospitals and primary care physicians available in each city on a per-capita basis. Patient-reported metrics such as doctor quality, ease of getting an appointment and wait times at appointments were also calculated into the final rankings.
Click here to see the full list of city rankings.
Teva receives favorable court decision regarding generic Celebrex
JERUSALEM — Teva Pharmaceutical Industries announced on Friday that the U.S. District Court for the Northern District of West Virginia has denied a motion filed by Mylan and issued an opinion and order affirming a decision by the FDA under which Teva should receive sole 180-day “first-to-file” exclusivity for generic Celebrex (celecoxib) 100-, 200- and 400-mg capsules.
On April 17, Teva entered into a settlement agreement with Pfizer related to Teva’s generic version of Celebrex (celecoxib) 50-, 100-, 200- and 400-mg capsules in the United States. Under the terms of the settlement, Teva may launch its generic versions in December 2014, or earlier under certain circumstances.
Teva has received tentative approval from the FDA for all strengths. Sales of Celebrex were $2.2 billion in the U.S. according to IMS data as of December 2013.
Sephora offers new 3-D Augmented Reality Mirror in Milan
MILAN, Italy — Beauty retailer Sephora and ModiFace, a global augmented reality virtual makeover technology provider, have launched in Milan a 3-D Augmented Reality Mirror that can simulate cosmetics on a user’s face in real-time and in 3-D.
The new technology, created by ModiFace, tracks the precise location of a user’s facial features and applies eye shadow colors directly on the video feed from a camera. Sephora customers can:
- Try any number of cosmetic colors — instantaneously and virtually — by tapping on a shade palette on the Beauty Mirror screen;
- Preview unique textures of eye shadow including glittery, sparkly and shiny shadow textures; and
- View all eye shadows from different angles as they turn their face from side to side, enabling customers to virtually try out products quickly in a store and to make better informed purchasing decisions.
Originally announced in 2014, the Sephora 3-D Augmented Reality mirror is the result of more than three years of research and development.
“We believe ModiFace’s 3-D Augmented Reality Mirror will be a breakthrough technology for our customers as they virtually try out different eye shadow shades quickly and easily," stated Antonio Ferreira de Almeida, GM, Sephora Italy.